Research highlights the use of multimodal machine learning to identify non-small cell lung cancer patients predicted to derive the most benefit from combination immunotherapy BOSTON and ROLLE,...

Adela's tissue-agnostic MRD test has been clinically validated to predict and surveil for recurrence in patients with head & neck cancer, regardless of HPV status The test identified recurrences...

At RE+ 2024, Sunwoda made a significant impact under the theme "Sunwoda Inside," underscoring its leadership in providing end-to-end energy storage solutions. With 27 years of experience in...

Updated Phase 1 dose-escalation data from ARROS-1 and ALKOVE-1 clinical trials continue to support potential best-in-class profiles for zidesamtinib and NVL-655 Rapid enrollment in Phase 2...

XCMG Machinery ("XCMG", SHE: 000425) is set to present its largest-ever collection of mining equipment at MinExpo 2024, taking place from September 24-26 in Las Vegas. Visitors can find XCMG at...